Company | Group | |||||
2020 | 2019 | (R’million) | 2020 | 2019 Restated* |
||
3 | Operating income before impairments and abnormal items | |||||
Operating income has been determined after charging/(crediting): | ||||||
External auditors’ remuneration | 25,9 | 23,6 | ||||
– Audit fees | 23,4 | 22,1 | ||||
– Other fees and expenses | 2,5 | 1,5 | ||||
Internal auditors’ remuneration | 9,1 | 10,3 | ||||
Lease charges** | 46,5 | 201,6 | ||||
– On land and buildings | 21,3 | 79,7 | ||||
– On plant, equipment and vehicles | 25,2 | 121,9 | ||||
Loss on disposal of plant, equipment and vehicles | 6,0 | – | ||||
Research, development and related expenditure | 51,5 | 57,5 | ||||
IFRS 2 charges | 66,1 | 60,9 | ||||
– Cash settled | (3,3) | 2,5 | ||||
– Equity settled, including BEE-related IFRS 2 charges | 69,4 | 58,4 | ||||
Staff costs | 3 702,3 | 3 337,9 | ||||
Employer’s contribution to retirement funding | 271,8 | 255,3 | ||||
Employer’s contribution to medical aid | 90,0 | 82,6 | ||||
– | (0,1) | Foreign exchange profit | (25,2) | (4,7) | ||
Rental and fee income | (4,1) | (4,0) |